| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/22/2023 |
SC 13G/A
| Archon Capital Management LLC reports a 10% stake in Neuronetics, Inc. |
| 08/18/2023 |
SC 13D/A
| Cannell Capital reports a 8.4% stake in Neuronetics, Inc. |
| 08/11/2023 |
4
| CASCELLA ROBERT (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 28,500 shares
@ $1.813, valued at
$51.7k
|
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/08/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
4
| MACAN WILLIAM ANDREW (EVP, GC, CCO and CS) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Sold 2,645 shares
@ $2.13, valued at
$5.6k
|
|
| 07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
SC 13D/A
| Cannell Capital reports a 10% stake in Neuronetics, Inc. |
| 06/01/2023 |
4
| CANNELL CAPITAL LLC (10% Owner) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Disposed of 286,596 shares
@ $0 |
|
| 05/30/2023 |
4
| MUIR GLENN P (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 36,364 shares
@ $0 |
|
| 05/30/2023 |
4
| JAEGER WILFRED E (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 36,364 shares
@ $0 |
|
| 05/30/2023 |
4
| CONLEY SHERYL L (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 36,364 shares
@ $0 |
|
| 05/30/2023 |
4
| CASCELLA ROBERT (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 45,455 shares
@ $0 |
|
| 05/30/2023 |
4
| Capper Joseph H (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 36,364 shares
@ $0 |
|
| 05/30/2023 |
4
| Rosengarten Megan (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 36,364 shares
@ $0 |
|
| 05/26/2023 |
4
| BAKEWELL JOHN K (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Sold 14,400 shares
@ $2.7, valued at
$38.9k
Granted 36,364 shares
@ $0 |
|
| 05/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 05/09/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 04/13/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
|